CClinicalTrials.gg
CompletedNCT07256990Updated Dec 8, 2025

An e-Learning Program for Nurses on Evidence-Based Prevention of CKD

An interventional study of CKD-prevention e-learning course (Your Kidney... our priority) in Nursing Education, sponsored by Shandong University. Completed at 1 site in Syria. Open to participants aged 18 Years to 60 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-12-08.

Sponsored by Shandong University · Not applicable, Interventional, and Health services research

From the registry’s dates

  • Registered 4 months after the study started (first participant enrolled Jun 2025, registered Nov 2025).
Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Not applicable
Ages
18 Years to 60 Years
Sex
All
01

Study summary

Electronic training course to help Syrian nurses prevent chronic kidney disease Why are the investigators doing this study? Chronic kidney disease (CKD) is common in Syria, yet many nurses have not received up-to-date training on early detection or patient education for risk reduction. The investigators aim to determine whether a brief, phone-friendly online course can improve nurses' knowledge, day-to-day practice, confidence, and satisfaction.

What will happen? Registered nurses employed in nephrology, cardiology, or endocrinology units will be invited to participate.

Each nurse will complete a short online quiz and questionnaire before the course.

Participants will then work through seven brief learning modules (videos, posters, case stories, quizzes) on a phone or computer over four weeks.

Two weeks after the final module, participants will repeat the same quiz and questionnaire so the investigators can measure any change.

The investigators will also request feedback on course acceptability and suggestions for improvement.

Possible benefits If the course proves effective, the investigators plan to offer it to additional nurses across Syria and distribute the materials free of charge.

Number of volunteers the investigators plan to enrol 30 nurses (single group; no randomisation). Primary outcome the investigators will measure Change in CKD-prevention knowledge score from baseline to immediately post-course.

Read the detailed description

Study design Prospective, single-arm, pre-test/post-test pilot trial to estimate preliminary effect, feasibility, and acceptability of a seven-module asynchronous e-learning programme on Syrian hospital nurses' CKD-prevention knowledge, self-reported practice, confidence, and satisfaction. No control or randomization will be used.

Setting \& recruitment Thirty registered nurses employed in nephrology, cardiology, or endocrinology wards of Syrian hospitals will be recruited through convenience sampling (hospital WhatsApp groups, professional associations, social-media promotion). Inclusion criteria: (1) registered nurse license, (2) access to smartphone/tablet, (3) willingness to provide electronic informed consent. A dedicated WhatsApp group will be created for announcements and technical support only; no teaching will occur in this group.

Intervention development Content was constructed by the study team and refined through a two-round Delphi panel (two nephrologists, two nutritionists, one senior nurse). Modules map to 2022 KDIGO prevention guidelines and WHO self-care recommendations. All assets (slide-casts ≤ 12 min, branching case vignettes, infographic posters, patient hand-outs) will be bilingual (Arabic/English subtitles) and compressed to ≤ 25 MB to allow offline download.

Delivery logistics Google Classroom will release two modules per week for four weeks. Each module contains: (1) voiced micro-lecture or animation, (2) interactive case study with branched questions, (3) downloadable poster \& patient hand-out, (4) 5-item quiz (pass mark 75 %; unlimited attempts). Engagement analytics (views, quiz attempts, offline downloads) will be extracted from the Google Workspace admin console. Participants will receive a 5 USD mobile-data stipend to mitigate connectivity barriers; no other incentive will be offered.

Data collection timeline Day 0 - Baseline Qualtrics link (demographics, 38-item CKD-knowledge scale, 7-item attitude, 5-item practice, 24-item confidence).

Weeks 1-4 - Intervention delivered. Week 6 - Post-intervention Qualtrics link (same instruments plus 30-item E-Learning Satisfaction Questionnaire and one open-ended feedback item).

No biological samples or patient-level data will be collected. Outcomes Primary: change in CKD-prevention knowledge score (0-38; KR-20 = 0.83). Secondary: change in attitude (7-item, 5-point Likert, CVI = 0.89), self-reported practice (5-item, test-retest r = 0.78), confidence (24-item, Cronbach α = 0.92); module-quiz performance (% correct, attempts to pass); overall satisfaction (0-100; α = 0.93 Arabic version); qualitative feedback (inductive thematic analysis, two independent coders, κ target > 0.80).

Sample size Thirty participants will be enrolled. This number meets pilot-guidance (≥ 30) to detect a large within-group effect (Cohen's d ≥ 0.8) and allows 15 % attrition.

Analysis plan Normality will be examined with Shapiro-Wilk tests. Pre-post differences will be analysed using Wilcoxon signed-rank tests (two-tailed, α = 0.05). Effect size will be reported as r (Z/√N) and Cohen's d with 95 % CIs. Feasibility benchmarks: recruitment ≥ 80 % of target within four weeks, module-completion ≥ 70 %, mean satisfaction ≥ 4/5. Qualitative data will follow Braun \& Clarke six-step thematic analysis.

Ethics \& dissemination Approvals obtained from Shandong University IRB (No. 2023-R-091) and Tishreen University IRB (Ref. N14218). Electronic informed consent will be secured; withdrawal permitted at any time without penalty. Data will be stored on password-protected Qualtrics and OneDrive (256-bit AES). Findings will be submitted to a peer-reviewed journal and presented at nephrology/nursing-education conferences. De-identified dataset and e-learning package will be shared on reasonable request after publication.

02

Conditions studied

  • Nursing Education

Keywords

  • e-learning
  • nurses
  • CKD prevention
  • Syria
  • pilot study
  • pre-post
  • professional development
03

In context

Lead sponsor

Shandong University is the lead sponsor of 284 studies on the registry; 59 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  1. Registered nurse currently employed in a Syrian hospital
  2. Works in nephrology, endocrinology, or cardiology ward
  3. Age 18 - 60 years
  4. Has smartphone or computer access with internet connection
  5. Willing to complete pre- and post-course questionnaires
  6. Provides electronic informed consent

Exclusion criteria

Exclusion Criteria:

  1. Not a registered nurse (e.g., nursing assistant, student)
  2. Outside the specified age range
  3. Unable to access online materials (no device / no internet)
  4. Previous participation in the same e-learning pilot
  5. Refuses to give informed consent
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
30 participants (actual)

Study arms

  • Experimental
    E-learning group

    All eligible nurses receive the 7-module asynchronous e-learning programme on evidence-based CKD prevention.

    Behavioral: CKD-prevention e-learning course (Your Kidney... our priority)

Interventions

  • BehavioralCKD-prevention e-learning course (Your Kidney... our priority)

    'Seven online modules (videos, infographics, case studies, quizzes) delivered via Google Classroom over 4 weeks. Content covers CKD risk-factor screening, lifestyle \& dietary counselling, co-morbidity management, patient education, and program evaluation. Each module includes a short lecture (\<12 min), interactive case, downloadable poster, and 5-item quiz (pass ≥75 %). Participants can download materials for offline use.'

06

What researchers measure

Primary outcomes

  1. Change in CKD-prevention knowledge score from baseline to immediately post-intervention

    38-item multiple-choice quiz; score range 0-38; higher score indicates better knowledge.

    Time frame: Baseline and Week 6

Secondary outcomes

  1. Change in self-reported practice

    5-item Likert scale (1-5); total score 5-25.

    Time frame: Baseline and Week 6

  2. Change in confidence level

    24-item Likert scale (1-5); total score 24-120.

    Time frame: Baseline and Week 6

  3. Change in attitude toward CKD prevention

    7-item Likert scale (1-5); total score 7-35.

    Time frame: Baseline and Week 6

  4. Overall satisfaction with the e-learning programme

    30-item validated satisfaction scale (0-100 %).

    Time frame: Week 6

  5. Module quiz performance

    Percentage of correct answers per 5-item quiz.

    Time frame: After each of the 7 modules (Weeks 1-4)

07

Study locations

1 site
  • Tishreen University
    Latakia, 000000, Syria
08

References and documents

Individual participant data

Plan to share: Yes — De-identified participant-level data for knowledge, practice, confidence, attitude, and satisfaction scores, together with the study protocol and analytic code, will be made available to researchers who provide a methodologically sound proposal approved by the corresponding author. Data will be shared via a secure, password-protected cloud link for 5 years after publication. Proposals should be directed to fatema92w@gmail.com

Supporting information: Study protocol, Sap, Icf, Csr, Analytic code

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 8, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07256990
Lead sponsor
Shandong University
Responsible party
Fatema Ahmed (Principal Investigator, Shandong University) — Principal investigator
First posted
Dec 2, 2025
Start date
Jun 21, 2025
Primary completion
Jul 31, 2025
Completion
Oct 16, 2025
Last update
Dec 8, 2025

Study contacts

Kefang Wang, PhD
study director · Shandong University , School of Nursing and Rehabilitation

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion